Adicet Bio Inc

General ticker "ACET" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $90.5M

Adicet Bio Inc does not follow the US Stock Market performance with the rate: -32.5%.

Estimated limits based on current volatility of 3.7%: low 0.85$, high 0.91$

Factors to consider:

  • Current price 23.4% below estimated low
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.17$, 3.42$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.99$, 4.94$]

Financial Metrics affecting the ACET estimates:

  • Negative: Non-GAAP EPS, $ of -2.87 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share, $ of 0 <= 0
  • Negative: Operating cash flow per share per price, % of -61.13 <= 2.35

Similar symbols

Short-term ACET quotes

Long-term ACET plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $9.73MM $24.99MM $0.00MM
Operating Expenses $71.16MM $97.54MM $152.04MM
Operating Income $-61.43MM $-72.55MM $-152.04MM
Non-Operating Income $-0.69MM $2.76MM $9.38MM
Interest Expense $0.18MM $0.08MM $0.00MM
R&D Expense $48.94MM $71.25MM $106.04MM
Income(Loss) $-62.12MM $-69.79MM $-142.66MM
Taxes $-0.12MM $0.00MM $0.00MM
Profit(Loss) $-62.00MM $-69.79MM $-142.66MM
Stockholders Equity $303.13MM $292.34MM $170.18MM
Assets $338.94MM $330.69MM $207.29MM
Operating Cash Flow $-51.05MM $-44.77MM $-93.72MM
Capital expenditure $13.05MM $16.78MM $4.46MM
Investing Cash Flow $-2.80MM $-16.78MM $-4.46MM
Financing Cash Flow $242.69MM $41.51MM $0.24MM
Earnings Per Share* $-2.00 $-1.63 $-3.31

* EPS are Split Adjusted, recent splits may be reflected with a delay.